Chemoinformaics analysis of 2-Octenoic acid, 4,5,7-trhydroxy
Molecular Weight | 190.195 | nRot | 5 |
Heavy Atom Molecular Weight | 176.083 | nRig | 2 |
Exact Molecular Weight | 190.084 | nRing | 0 |
Solubility: LogS | -0.089 | nHRing | 0 |
Solubility: LogP | -1.54 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 26.7051 |
nHD | 4 | BPOL | 14.9129 |
QED | 0.368 |
Synth | 3.468 |
Natural Product Likeliness | 1.215 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.014 |
Pgp-sub | 0.991 |
HIA | 0.227 |
CACO-2 | -5.184 |
MDCK | 0.00403888 |
BBB | 0.568 |
PPB | 0.270761 |
VDSS | 0.641 |
FU | 0.825918 |
CYP1A2-inh | 0.004 |
CYP1A2-sub | 0.096 |
CYP2c19-inh | 0.016 |
CYP2c19-sub | 0.116 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.404 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.117 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.099 |
CL | 2.113 |
T12 | 0.929 |
hERG | 0.034 |
Ames | 0.03 |
ROA | 0.024 |
SkinSen | 0.721 |
Carcinogencity | 0.02 |
EI | 0.816 |
Respiratory | 0.869 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.930353 |